End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
111,500 KRW | +1.64% | -0.80% | -4.54% |
04-24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
04-12 | AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd | CI |
Business Summary
Number of employees: 1,679
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
102.5
%
| 1,320,122 | 103.1 % | 1,409,520 | 102.5 % | +6.77% |
Consolidated Adjustment
-4.8
%
| -51,583 | -4.0 % | -66,100 | -4.8 % | +28.14% |
Service
1.7
%
| 9,842 | 0.8 % | 23,648 | 1.7 % | +140.29% |
Others
0.6
%
| 1,711 | 0.1 % | 8,262 | 0.6 % | +382.84% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
89.4
%
| 1,146,711 | 89.6 % | 1,229,284 | 89.4 % | +7.20% |
International
15.4
%
| 184,964 | 14.4 % | 212,145 | 15.4 % | +14.70% |
Consolidated Adjustment
-4.8
%
| -51,583 | -4.0 % | -66,100 | -4.8 % | +28.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seung-Ho Jeon
CEO | Chief Executive Officer | 49 | 31/03/03 |
Chung-Woo Lee
AUD | Comptroller/Controller/Auditor | 58 | - |
Jin-Hwan Park
PRN | Corporate Officer/Principal | 56 | 30/09/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong-Cheol Kim
BRD | Director/Board Member | 53 | 22/03/18 |
Seung-Ho Jeon
CEO | Chief Executive Officer | 49 | 31/03/03 |
Dae-Duk Kim
BRD | Director/Board Member | 61 | 28/03/22 |
Chang-Jae Lee
BRD | Director/Board Member | 48 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,586,575 | 4,356,734 ( 37.60 %) | 80,305 ( 0.6931 %) | 37.60 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HANALL BIOPHARMA CO., LTD. 30.85% | 16,115,745 | 30.85% | 420,937,941 $ |
EVOLUS, INC. 5.10% | 3,136,869 | 5.10% | 35,948,519 $ |
80,305 | 0.69% | 6,501,794 $ | |
INVENTAGE LAB, INC. 0.99% | 83,326 | 0.99% | 641,479 $ |
Company contact information
Daewoong Pharmaceutical Co., Ltd.
35-14 Jeyakgongdan 4-gil Hyangnam-eup
18623, Hwaseong-si
+
http://www.daewoong.co.krSector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.54% | 923M | |
+22.69% | 43.81B | |
+25.56% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- A069620 Stock
- Company Daewoong Pharmaceutical Co., Ltd